Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Budesonide formoterol inhalation powder spray (II) (xinbike Doubao)

1. Asthma This product is suitable for the combined application of inhaled corticosteroids and long-acting corticosteroids β Routine treatment of asthmatic patients with 2-receptor agonists: inhaled corticosteroids and "on-demand" short-term effects β Patients whose symptoms cannot be well controlled by 2-receptor agonists; Or inhaled corticosteroids and long-acting β 2-receptor agonists, patients whose symptoms have been well controlled. 2. Chronic obstructive pulmonary disease (COPD) This product is suitable for symptomatic treatment of COPD patients (including chronic bronchitis and emphysema) with FEV1 < 70% of the expected normal value after the use of bronchodilators and patients with a history of acute exacerbation despite the standardized use of dilators. More role
App download minus 10 yuan
Common name:
Budesonide formoterol inhalation powder spray
Product No.:
B14200070477
Approval No.:
H20140458 (inquired by the State Drug Administration)
Jianke price:
¥330.00
Product specification:
(160 μ g+4.5 μ g) * 60 suction (320 μ g+9 μ g) * 60 suction (80 μ g+4.5 μ g) * 60 suction (160 μ g+4.5 μ g) * 120 suction
Manufacturer:
AstraZeneca AB
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Budesonide formoterol inhalation powder spray (II) (xinbike Doubao)
Main raw materials This product is a compound preparation, and its component is budesonide (160) μ G / suction) and formoterol fumarate (4.5 μ G / suction).
Main role 1. Asthma This product is suitable for the combined application of inhaled corticosteroids and long-acting corticosteroids β Routine treatment of asthmatic patients with 2-receptor agonists: inhaled corticosteroids and "on-demand" short-term effects β Patients whose symptoms cannot be well controlled by 2-receptor agonists; Or inhaled corticosteroids and long-acting β 2-receptor agonists, patients whose symptoms have been well controlled. 2. Chronic obstructive pulmonary disease (COPD) This product is suitable for symptomatic treatment of COPD patients (including chronic bronchitis and emphysema) with FEV1 < 70% of the expected normal value after the use of bronchodilators and patients with a history of acute exacerbation despite the standardized use of dilators.
Product specification (160 μ g+4.5 μ g) * 60 suction
Usage and dosage 1. Asthma This product is not used for the initial treatment of asthma. This product should be used individually and the dose should be adjusted according to the severity of the disease. This requires attention not only when starting to use the compound preparation, but also when adjusting the maintenance dose. If the dose of combined treatment required by a patient exceeds the range of compound preparation, an appropriate dose should be added β Single agent inhaled preparations of 2-receptor agonists and / or corticosteroids. The dose should be gradually reduced to the minimum dose that can effectively control the patient's asthma symptoms. Patients should be reviewed and evaluated regularly by doctors to ensure that they use the best dose of this product. If the symptoms can be controlled for a long time after using the minimum recommended amount, the next step is to consider trying to use inhaled corticosteroids alone. There are two ways to use this product: A. Maintenance treatment: This product is used as routine maintenance treatment, combined with rapid effective bronchodilator as relief drug. B. Maintenance and remission treatment: This product is used as daily maintenance treatment and on-demand remission treatment. A. Maintenance treatment: This product is used as routine maintenance treatment, combined with rapid acting bronchodilator as relief drug. It is recommended that patients carry another rapid bronchodilator with them at all times. Adults (18 years old and over): 1-2 times a day. Some patients may need to use up to 4 breaths / time, twice a day. Teenagers (12-17 years old): 1-2 times a day. In routine treatment, when the symptoms can be effectively controlled by twice a day, the dose should be gradually reduced to the lowest effective dose, or even once a day. The increase of rapid bronchodilator dosage indicates that the potential condition has worsened, and asthma treatment should be reassessed. Children (6 years and older): a lower dose is available for children aged 6-11 years. (see the inner packaging manual for details)
manufacturing enterprise AstraZeneca AB
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Budesonide formoterol inhalation powder spray (II) (xinbike Doubao)

[common name] Budesonide formoterol inhalation powder spray

[specification and model] (160 μ g+4.5 μ g) * 60 suction

[manufacturer] AstraZeneca AB

[drug type] Western medicine

[approval No.] H20140458

[validity period] 24 months

[functional indications] 1. Asthma This product is suitable for the combined application of inhaled corticosteroids and long-acting corticosteroids β Routine treatment of asthmatic patients with 2-receptor agonists: inhaled corticosteroids and "on-demand" short-term effects β Patients whose symptoms cannot be well controlled by 2-receptor agonists; Or inhaled corticosteroids and long-acting β 2-receptor agonists, patients whose symptoms have been well controlled. 2. Chronic obstructive pulmonary disease (COPD) This product is suitable for symptomatic treatment of COPD patients (including chronic bronchitis and emphysema) with FEV1 < 70% of the expected normal value after the use of bronchodilators and patients with a history of acute exacerbation despite the standardized use of dilators.

[usage and dosage] 1. Asthma This product is not used for the initial treatment of asthma. This product should be used individually and the dose should be adjusted according to the severity of the disease. This requires attention not only when starting to use the compound preparation, but also when adjusting the maintenance dose. If the dose of combined treatment required by a patient exceeds the range of compound preparation, an appropriate dose should be added β Single agent inhaled preparations of 2-receptor agonists and / or corticosteroids. The dose should be gradually reduced to the minimum dose that can effectively control the patient's asthma symptoms. Patients should be reviewed and evaluated regularly by doctors to ensure that they use the best dose of this product. If the symptoms can be controlled for a long time after using the minimum recommended amount, the next step is to consider trying to use inhaled corticosteroids alone. There are two ways to use this product: A. Maintenance treatment: This product is used as routine maintenance treatment, combined with rapid effective bronchodilator as relief drug. B. Maintenance and remission treatment: This product is used as daily maintenance treatment and on-demand remission treatment. A. Maintenance treatment: This product is used as routine maintenance treatment, combined with rapid acting bronchodilator as relief drug. It is recommended that patients carry another rapid bronchodilator with them at all times. Adults (18 years old and over): 1-2 times a day. Some patients may need to use up to 4 breaths / time, twice a day. Teenagers (12-17 years old): 1-2 times a day. In routine treatment, when the symptoms can be effectively controlled by twice a day, the dose should be gradually reduced to the lowest effective dose, or even once a day. The increase of rapid bronchodilator dosage indicates that the potential condition has worsened, and asthma treatment should be reassessed. Children (6 years and older): a lower dose is available for children aged 6-11 years. (see the inner packaging manual for details)

[adverse reactions] 1. The most common adverse reaction is β Predictable adverse pharmacological reactions such as tremor and palpitation during treatment with 2-receptor agonists. 2. Common (> 1 / 100): (1) Central nervous system: headache; (2) Cardiovascular system: palpitation; (3) Musculoskeletal system: tremor; (4) Respiratory tract: oral and pharyngeal Candida infection, mild pharyngeal irritation, cough and hoarseness. 3. Uncommon: (1) Cardiovascular system: tachycardia; (2) Skeletal muscle system: muscle spasm; (3) Central nervous system: anxiety, restlessness, tension, nausea, dizziness, sleep disorder. 4. Rare (< 1 / 1000) (1) Skin: rash, measles, pruritus; (2) Respiratory tract: bronchospasm. 5. Some of them may be very serious adverse reactions: (1) Budesonide: psychiatric symptoms such as depression, abnormal behavior (mainly in children), symptoms and signs of systemic effects of glucocorticoids (including adrenal dysfunction), rapid and delayed allergic reactions (including dermatitis, angioneuroedema and bronchospasm), and swelling. (see the inner packaging manual for details)

[precautions] Athletes should use it with caution. It is necessary to gradually reduce the dose when stopping this product. Do not stop using it suddenly. I. if the treatment is found to be ineffective or the required dose exceeds the maximum recommended dose of this product, the patient should seek medical help. Sudden or progressive exacerbation of asthma or COPD symptoms has the possibility of life-threatening, and the patient needs urgent medical treatment. In this case, consideration should be given to the need for increased corticosteroid treatment, such as a course of oral corticosteroids, or antibiotics in the event of infection. Patients should be advised to carry relief inhaled drugs, such as this product (for patients using this product for relief and maintenance therapy) or other rapid acting bronchodilators (for patients using this product for maintenance therapy). Patients should be reminded to inhale a maintenance dose of this product according to the prescription even if there are no symptoms. Before exercise, there is no research data on the preventive use of this product. The relief treatment of this product should be used when asthma symptoms worsen, rather than routine preventive use, such as before exercise. If preventive use is required, consider using a separate rapid acting bronchodilator. (see the inner packaging instructions for details) please read the instructions carefully and follow the doctor's instructions.

[taboo] It is forbidden for patients with allergic reactions to budesonide, formoterol or inhaled lactose.

[listing Permit Holder] Astrazenecaab (Sweden)

[packaging unit] bottle

[main ingredients] This product is a compound preparation, and its component is budesonide (160) μ G / suction) and formoterol fumarate (4.5 μ G / suction).

[character] This product is a multi dose powder inhaler. The contents in the storage type dry powder inhalation device are white or quasi white particles.

[applicable population] Adult, elderly

[medication for pregnant and lactating women] There is no clinical data on the use of budesonide formoterol powder inhaler (xinbike Duobao) or both formoterol and budesonide in pregnant women. Studies on the reproductive toxicity of compound preparations to animals have not been carried out. There is insufficient information on the use of formoterol by pregnant women. (see the inner packaging manual for details)

[medication for children] See [usage and dosage]

[medication for elderly patients] See [usage and dosage]

[storage] Sealed, 30 ℃ lower temperature.

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Budesonide formoterol inhalation powder spray (II) (xinbike Doubao)

    ¥330.00

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!